Immatics combines the discovery of true targets for cancer immunotherapies with the development of the right T cell receptors with the goal of enabling a robust and specific T cell response against these targets. 

Pharmaceutical

Immatics

Harpreet Singh

Lauren Schroeder

Mamta Kalra

Tamara Louw

Zoe Coughlin

Norbert Hilf

Jason Braun

Nina Möker

Evelyn Roth-Geissler

Kerry Sieger

Ali Mohamed

Claudia Blattner

Miriam Meyer

Steffen Walter

Carsten Reinhardt

Toni Weinschenk

Cedrik Britten

Rainer Kramer

Dominik Maurer

Michael Mølhøj

Edward Sturchio

Arnd Christ

The Scientific Advisory Team at Immatics provides expert guidance on the latest scientific advancements and strategic direction for cancer immunotherapy research. Comprised of distinguished members in the field, they ensure the alignment of Immatics' goals with cutting-edge science and clinical applications, fostering innovative solutions for robust and specific T cell responses against cancer targets.

Scientific Advisory Team

Vice Presidents

Leadership Team

Leadership Tübingen

Scientific Advisory Team

About

Team members

Other teams at Immatics

Vice Presidents

Leadership Team

Leadership Tübingen